Patent · US Active

Systems and methods for achieving target post-procedure fraction of cells remaining, hematocrit, and blood volume during a therapeutic red blood cell exchange procedure with optional isovolemic hemodilution

US9393359B2 · kind B2 · utility

17Cited by
4References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 15, 2013
Grant dateJul 19, 2016
Priority date
Expiry dateFeb 8, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2230/207
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Systems and methods for performing a therapeutic red blood cell exchange procedure are disclosed. In one aspect, a system includes a first flow path for flowing whole blood from a patient. A separator communicates with the first flow path for separating at least red blood cells from plasma. Second and third flow paths communicate with the separator for respectively flowing the separated plasma and red blood cells from the separator. A flow controller is associated with the flow paths to control fluid communication between the flow paths. The controller is configured to perform the procedure to achieve a target fraction of patient cells remaining, target hematocrit, and a target patient fluid volume change at the completion of the procedure based on data input by the operator.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.